Web of Science:
Exploring Benzo[b][1,4]Thiazine Derivatives: Multitarget Inhibition, Structure-Activity Relationship, Molecular Docking, and ADMET Analysis

dc.contributor.authorAlishba, I.
dc.contributor.authorAli, I.
dc.contributor.authorHameed, S.
dc.contributor.authorKhan, K.M.
dc.contributor.authorSalar, U.
dc.contributor.authorTaha, M.
dc.contributor.authorSadeghian, N.
dc.contributor.authorTaslimi, P.
dc.contributor.authorTuzun, B.
dc.contributor.authorÖzerkan, D.
dc.contributor.authorDedeakayogullari, H.
dc.contributor.authorUlukaya, E.
dc.date.accessioned2024-10-30T11:09:45Z
dc.date.available2024-10-30T11:09:45Z
dc.date.issued2024.01.01
dc.description.abstractA series of benzothiazine derivatives (1-17) were synthesized via an intermolecular cyclo condensation reaction involving 2-aminothiophenol (i) and substituted phenacyl bromide (ii). Structural elucidation of these synthetic derivatives utilized EI-MS, HR-EIMS, H-1 NMR, and C-13 NMR spectroscopic techniques. The synthesized analogs were evaluated against key enzyme targets (acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and alpha-glucosidase (alpha-Glu)) and tested for cytotoxicity against various cancer cell lines. Six compounds were selected based on their inhibition profiles, exhibiting significant inhibitory potential against enzymes. In silico studies corroborated the observed inhibitory activities, aligning closely with experimental outcomes. Additionally, an ADME/T study provided insights into pharmacokinetic and safety profiles, identifying promising candidates for future drug development efforts.
dc.identifier.doi10.1002/slct.202404087
dc.identifier.eissn
dc.identifier.endpage
dc.identifier.issn2365-6549
dc.identifier.issue38
dc.identifier.startpage
dc.identifier.urihttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=dspace_ku&SrcAuth=WosAPI&KeyUT=WOS:001336599100001&DestLinkType=FullRecord&DestApp=WOS_CPL
dc.identifier.urihttps://hdl.handle.net/20.500.12597/33696
dc.identifier.volume9
dc.identifier.wos001336599100001
dc.language.isoen
dc.relation.ispartofCHEMISTRYSELECT
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectADME/T
dc.subjectAlzheimer's disease
dc.subjectCancer
dc.subjectDiabetes
dc.subjectSynthesis
dc.titleExploring Benzo[b][1,4]Thiazine Derivatives: Multitarget Inhibition, Structure-Activity Relationship, Molecular Docking, and ADMET Analysis
dc.typeArticle
dspace.entity.typeWos

Files